医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2015年
5期
922-924
,共3页
急性冠状动脉综合征/并发症%心律失常 ,心性/并发症%心血管药物(中药)/治疗应用%血流动力学
急性冠狀動脈綜閤徵/併髮癥%心律失常 ,心性/併髮癥%心血管藥物(中藥)/治療應用%血流動力學
급성관상동맥종합정/병발증%심률실상 ,심성/병발증%심혈관약물(중약)/치료응용%혈류동역학
Acute Coronary Syndrome/CO%Arrhythmias,Cardiac/CO%CARDIOVASCULAR AGENTS (TCD)/TU%Hemodynamics
【目的】探究参松养心胶囊治疗急性冠状动脉综合征（ACS ）合并心律失常患者的临床疗效。【方法】选择本院就诊的72例ACS合并心律失常患者，随机将其分为对照组与观察组，每组36例。对照组给予常规治疗，观察组在此基础上加用参松养心胶囊。观察检测两组患者治疗总有效率、血流动力学、血液流变学及相关炎症因子水平。【结果】观察组治疗总有效率为97．22％，高于对照组患者的66．67％，其差异具有统计学意义（ P＜0．01）。治疗后，观察组血流动力学参数、血液流变学各指标及炎症因子水平均低于对照组患者，差异均具有统计学意义（均 P ＜0．05）。【结论】参松养心胶囊能够降低ACS合并心律失常患者体内炎症因子水平，改善患者血流动力学及血液流变学指标，其治疗效果明显，值得临床推广使用。
【目的】探究參鬆養心膠囊治療急性冠狀動脈綜閤徵（ACS ）閤併心律失常患者的臨床療效。【方法】選擇本院就診的72例ACS閤併心律失常患者，隨機將其分為對照組與觀察組，每組36例。對照組給予常規治療，觀察組在此基礎上加用參鬆養心膠囊。觀察檢測兩組患者治療總有效率、血流動力學、血液流變學及相關炎癥因子水平。【結果】觀察組治療總有效率為97．22％，高于對照組患者的66．67％，其差異具有統計學意義（ P＜0．01）。治療後，觀察組血流動力學參數、血液流變學各指標及炎癥因子水平均低于對照組患者，差異均具有統計學意義（均 P ＜0．05）。【結論】參鬆養心膠囊能夠降低ACS閤併心律失常患者體內炎癥因子水平，改善患者血流動力學及血液流變學指標，其治療效果明顯，值得臨床推廣使用。
【목적】탐구삼송양심효낭치료급성관상동맥종합정（ACS ）합병심률실상환자적림상료효。【방법】선택본원취진적72례ACS합병심률실상환자，수궤장기분위대조조여관찰조，매조36례。대조조급여상규치료，관찰조재차기출상가용삼송양심효낭。관찰검측량조환자치료총유효솔、혈류동역학、혈액류변학급상관염증인자수평。【결과】관찰조치료총유효솔위97．22％，고우대조조환자적66．67％，기차이구유통계학의의（ P＜0．01）。치료후，관찰조혈류동역학삼수、혈액류변학각지표급염증인자수평균저우대조조환자，차이균구유통계학의의（균 P ＜0．05）。【결론】삼송양심효낭능구강저ACS합병심률실상환자체내염증인자수평，개선환자혈류동역학급혈액류변학지표，기치료효과명현，치득림상추엄사용。
[Objective]To explore the efficacy of Shensongyangxin capsules on acute coronary hemodynam‐ics in patients with arrhythmia complicated syndrome .[Methods] A total of 72 cases of arrhythmias at our hospital in patients with acute coronary syndrome (ACS) ,36 cases in each group were randomly divided into control and observation groups .The control group received conventional treatment ,on the basis of observation group plus Shensongyangxin capsules .[Results]For observation group ,the overall effective rate was 97 .22%versus 66 .67% in control group .The difference was statistically significant (χ2 =11 .359 ,P <0 .01) .After treatment ,systolic blood pressure ,diastolic blood pressure ,mean arterial pressure and heart rate in observa‐tion group were lower than those in control group .And the differences were statistically significant ( P <0 .01) .After treatment ,hemodynamic indices were lower in observation group than those in control group . And the differences were statistically significant ( P<0 .01) .After treatment ,all indices of inflammatory cy‐tokines were lower in observation group than those in control group .And the differences were statistically sig‐nificant ( P <0 .01) .[Conclusion]Using Shensongyangxin capsules can enhance body immunity ,inhibit in vi‐vo inflammatory response and improve hemodynamics in ACS patients with arrhythmia .
